Also trades as: 002399.SZ (SHZ) · $vol 9M · 9989.HK (HKSE) · $vol 0M

$0.47

+0.00 (+0.00%)

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 49 · $689.0M mcap · 411M float · 0.0000% daily turnover

Revenue

$5.3B -3.0% ▼

5Y CAGR: +2.7%

Gross Profit

$1.8B +85.9% ▲

5Y CAGR: +0.4%

Operating Income

$741M +186.1% ▲

5Y CAGR: -10.8%

Net Income

$647M +182.6% ▲

5Y CAGR: -9.4%

EPS (Diluted)

$0.44 +183.0% ▲

5Y CAGR: -12.3%

EBITDA

$1.2B +474.0% ▲

5Y CAGR: -8.1%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$5.3B	$6.4B	$7.2B	$5.4B	$5.3B
YoY Growth	+15.3%	+19.4%	+12.5%	-23.9%	-3.0%
Cost of Revenue	$3.2B	$4.3B	$4.8B	$4.5B	$3.5B
Gross Profit	$2.1B	$2.0B	$2.3B	$945M	$1.8B
Gross Margin	39.2%	31.9%	32.6%	17.4%	33.3%
R&D Expenses	$160M	$221M	$252M	$185M	$212M
SG&A Expenses	$560M	$573M	$665M	$590M	$455M
Operating Expenses	$961M	$1.1B	$1.2B	$1.8B	$1.0B
Operating Income	$1.3B	$227M	$829M	-$861M	$741M
Operating Margin	24.9%	3.6%	11.6%	-15.8%	14.0%
Interest Expense	$248M	$202M	$235M	$223M	$141M
Income Before Tax	$1.3B	$222M	$830M	-$928M	$726M
Tax Expense	$306M	-$11M	$115M	-$126M	$101M
Net Income	$1.0B	$241M	$727M	-$783M	$647M
Net Margin	19.2%	3.8%	10.2%	-14.4%	12.2%
EPS (Diluted)	$0.76	$0.16	$0.50	$-0.53	$0.44
EBITDA	$1.9B	$731M	$1.4B	-$320M	$1.2B
Shares Outstanding	1.35B	1.47B	1.47B	1.47B	1.47B

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$1.5B	$1.2B	$1.2B	$1.4B	$1.4B	$1.3B	$1.3B	$1.2B
Cost of Revenue	$950M	$869M	$807M	$1.0B	$926M	$864M	$876M	$821M
Gross Profit	$515M	$363M	$405M	$381M	$497M	$421M	$455M	$428M
Gross Margin	35.1%	29.5%	33.4%	27.3%	34.9%	32.7%	34.2%	34.2%
R&D Expenses	$48M	$49M	$82M	$40M	$63M	$50M	$36M	$46M
SG&A Expenses	$84M	$361M	-$135M	$191M	$14M	-$117M	$209M	$32M
Operating Expenses	-$58M	$243M	$567M	$202M	$192M	$654M	$247M	$355M
Operating Income	$586M	$120M	-$162M	$179M	$305M	-$233M	$207M	$73M
Operating Margin	40.1%	9.8%	-13.4%	12.8%	21.5%	-18.2%	15.6%	5.8%
Interest Expense	$32M	$31M	$31M	$22M	$18M	$16M	$13M	$13M
Income Before Tax	$586M	$120M	-$161M	$178M	$305M	-$239M	$208M	$73M
Tax Expense	$78M	$3M	-$7M	$22M	$40M	-$29M	$20M	$15M
Net Income	$509M	$116M	-$133M	$157M	$265M	-$204M	$188M	$88M
Net Margin	34.7%	9.5%	-11.0%	11.2%	18.6%	-15.9%	14.1%	7.0%
EPS (Diluted)	$0.35	$0.08	$-0.09	$0.11	$0.18	$-0.14	$0.13	$0.06
EBITDA	$655M	$181M	-$130M	$201M	$323M	-$223M	$221M	$233M
Shares Outstanding	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B

SHEZF OTC